Literature DB >> 22313876

Regulation of suppressive function of myeloid-derived suppressor cells by CD4+ T cells.

Srinivas Nagaraj1, Dmitry I Gabrilovich.   

Abstract

Myeloid derived suppressor cells play a critical role in T cell suppression in cancer. Here, we discuss the mechanisms of how MDSC suppress CD4(+) or CD8(+) T cells in an antigen dependent or non-dependent manner.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22313876      PMCID： PMC3349790          DOI： 10.1016/j.semcancer.2012.01.010

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN： 1044-579X            Impact factor:   15.707


  95 in total

1.  Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk.

Authors:  Xingguang Liu; Zhenzhen Zhan; Dong Li; Li Xu; Feng Ma; Peng Zhang; Hangping Yao; Xuetao Cao
Journal:  Nat Immunol       Date:  2011-03-27       Impact factor: 25.606

2.  Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer.

Authors:  Ping-Ying Pan; Ge Ma; Kaare J Weber; Junko Ozao-Choy; George Wang; Bingjiao Yin; Celia M Divino; Shu-Hsia Chen
Journal:  Cancer Res       Date:  2009-12-08       Impact factor: 12.701

3.  A schistosome-expressed immunomodulatory glycoconjugate expands peritoneal Gr1(+) macrophages that suppress naive CD4(+) T cell proliferation via an IFN-gamma and nitric oxide-dependent mechanism.

Authors:  O Atochina; T Daly-Engel; D Piskorska; E McGuire; D A Harn
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

Review 4.  Emerging Tim-3 functions in antimicrobial and tumor immunity.

Authors:  Kaori Sakuishi; Pushpa Jayaraman; Samuel M Behar; Ana C Anderson; Vijay K Kuchroo
Journal:  Trends Immunol       Date:  2011-06-21       Impact factor: 16.687

5.  Induction of myeloid-derived suppressor cells by tumor exosomes.

Authors:  Xiaoyu Xiang; Anton Poliakov; Cunren Liu; Yuelong Liu; Zhong-bin Deng; Jianhua Wang; Ziqiang Cheng; Spandan V Shah; Gui-Jun Wang; Liming Zhang; William E Grizzle; Jim Mobley; Huang-Ge Zhang
Journal:  Int J Cancer       Date:  2009-06-01       Impact factor: 7.396

6.  Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.

Authors:  Paola Filipazzi; Roberta Valenti; Veronica Huber; Lorenzo Pilla; Paola Canese; Manuela Iero; Chiara Castelli; Luigi Mariani; Giorgio Parmiani; Licia Rivoltini
Journal:  J Clin Oncol       Date:  2007-06-20       Impact factor: 44.544

7.  CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis.

Authors:  Bing Zhu; Yoshio Bando; Sheng Xiao; Kaiyong Yang; Ana C Anderson; Vijay K Kuchroo; Samia J Khoury
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

8.  Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer.

Authors:  Srinivas Nagaraj; Kapil Gupta; Vladimir Pisarev; Leo Kinarsky; Simon Sherman; Loveleen Kang; Donna L Herber; Jonathan Schneck; Dmitry I Gabrilovich
Journal:  Nat Med       Date:  2007-07-01       Impact factor: 53.440

Review 9.  The B7 family of immune-regulatory ligands.

Authors:  Mary Collins; Vincent Ling; Beatriz M Carreno
Journal:  Genome Biol       Date:  2005-05-31       Impact factor: 13.583

10.  Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence.

Authors:  Masaki Terabe; So Matsui; Jong-Myun Park; Mizuko Mamura; Nancy Noben-Trauth; Debra D Donaldson; Wanjun Chen; Sharon M Wahl; Steven Ledbetter; Bruce Pratt; John J Letterio; William E Paul; Jay A Berzofsky
Journal:  J Exp Med       Date:  2003-12-01       Impact factor: 14.307
View more
  39 in total

1.  Regulation of ozone-induced lung inflammation and injury by the β-galactoside-binding lectin galectin-3.

Authors:  Vasanthi R Sunil; Mary Francis; Kinal N Vayas; Jessica A Cervelli; Hyejeong Choi; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2015-02-25       Impact factor: 4.219

2.  Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.

Authors:  Su Jong Yu; Chi Ma; Bernd Heinrich; Zachary J Brown; Milan Sandhu; Qianfei Zhang; Qiong Fu; David Agdashian; Umberto Rosato; Firouzeh Korangy; Tim F Greten
Journal:  J Hepatol       Date:  2018-11-09       Impact factor: 25.083

3.  Scavenger Receptor Type B1 and Lipoprotein Nanoparticle Inhibit Myeloid-Derived Suppressor Cells.

Authors:  Michael P Plebanek; Debayan Bhaumik; Paul J Bryce; C Shad Thaxton
Journal:  Mol Cancer Ther       Date:  2017-12-27       Impact factor: 6.261

4.  Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma.

Authors:  Tamar Kapanadze; Jaba Gamrekelashvili; Chi Ma; Carmen Chan; Fei Zhao; Stephen Hewitt; Lars Zender; Veena Kapoor; Dean W Felsher; Michael P Manns; Firouzeh Korangy; Tim F Greten
Journal:  J Hepatol       Date:  2013-06-22       Impact factor: 25.083

5.  Δ9-Tetrahydrocannabinol-mediated epigenetic modifications elicit myeloid-derived suppressor cell activation via STAT3/S100A8.

Authors:  Jessica Margaret Sido; Xiaoming Yang; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Leukoc Biol       Date:  2015-02-20       Impact factor: 4.962

Review 6.  Myeloid-derived suppressor cells and their role in pancreatic cancer.

Authors:  M Pergamo; G Miller
Journal:  Cancer Gene Ther       Date:  2016-12-02       Impact factor: 5.987

Review 7.  The Tumor Macroenvironment: Cancer-Promoting Networks Beyond Tumor Beds.

Authors:  Melanie R Rutkowski; Nikolaos Svoronos; Alfredo Perales-Puchalt; Jose R Conejo-Garcia
Journal:  Adv Cancer Res       Date:  2015-05-21       Impact factor: 6.242

8.  Autologous dendritic cell based adoptive immunotherapy of patients with colorectal cancer-A phase I-II study.

Authors:  János Hunyadi; Csilla András; Imre Szabó; János Szántó; Kornélia Szluha; Sándor Sipka; Péter Kovács; Attila Kiss; Gyula Szegedi; István Altorjay; Péter Sápy; Péter Antal-Szalmás; László Tóth; György Fazekas; Éva Rajnavölgyi
Journal:  Pathol Oncol Res       Date:  2013-10-28       Impact factor: 3.201

9.  Antibiotic Perturbation of Gut Microbiota Dysregulates Osteoimmune Cross Talk in Postpubertal Skeletal Development.

Authors:  Jessica D Hathaway-Schrader; Heidi M Steinkamp; Michael B Chavez; Nicole A Poulides; Joy E Kirkpatrick; Michael E Chew; Emily Huang; Alexander V Alekseyenko; Jose I Aguirre; Chad M Novince
Journal:  Am J Pathol       Date:  2019-01-16       Impact factor: 4.307

Review 10.  Exosomes in tumor microenvironment influence cancer progression and metastasis.

Authors:  Christoph Kahlert; Raghu Kalluri
Journal:  J Mol Med (Berl)       Date:  2013-03-22       Impact factor: 4.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.